SCHEMBL8303576

SCHEMBL8303576

Bc1ccc2c(c1)C(=O)CCC2

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 10/20 0.53
▸ MAOB P27338 10/20 0.53
▸ CYP2A6 P11509 1/20 0.53
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ PRKCI P41743 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ PBRM1 Q86U86 1/20 0.46
▸ HSD17B1 P14061 1/20 0.42
▸ GRM5 P41594 1/20 0.40
▸ BAZ2B Q9UIF8 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.36
▸ PABPC1 P11940 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.36
▸ LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7891254 0.88 PBRM1 (0.59) MAOAMAOBCYP2A6MEN1KMT2A
SCHEMBL8131108 0.84 MAOA (0.61) MAOAMAOBCYP2A6MEN1KMT2A
SCHEMBL5543621 0.78 MAOA (0.55) MAOAMAOBCYP2A6MEN1KMT2A
SCHEMBL8870788 0.76 MAOA (0.53) MAOAMAOBCYP2A6MEN1KMT2A
SCHEMBL1274936 0.76 MAOA (0.59) MAOAMAOBCYP2A6MEN1KMT2A
SCHEMBL385554 0.76 PBRM1 (0.78) MAOAMAOBCYP2A6MEN1KMT2A
SCHEMBL769238 0.76 MAOA (0.53) MAOAMAOBCYP2A6MEN1KMT2A
SCHEMBL3665755 0.76 MAOA (0.53) MAOAMAOBCYP2A6MEN1KMT2A
SCHEMBL656011 0.76 CASP1 (0.55) MAOAMAOBCYP2A6MEN1KMT2A
SCHEMBL29446042 0.76 MAOA (0.53) MAOAMAOBCYP2A6MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008039520-A2 FUSED RING COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2008-04-03 — — WO disclosed
WO-2004094413-A1 PHENACYL 2-HYDROXY-3-DIAMINOALKANES ELAN PHARMACEUTICALS, INC. (US) 2004-11-04 — — WO disclosed
WO-2004094384-A2 (HETERO) ARYLAMIDE 2-HYDROXY-3-DIAMINOALKANES FOR USE IN THE TREATMENT OF ALZHEIMER’S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2004-11-04 — — WO disclosed
Send feedback